Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical sirolimus for cutaneous microcystic lymphatic malformations
2018-001359-11Phase 2Completed
- Sponsor
- CHRU Tours
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sirolimus in lymphangioma (2 arms), sponsored by CHRU Tours. Primary endpoint: Physician Global Assessment score comparison between sirolimus-treated and vehicle-treated areas. Started Jul 2018; status: completed.
02
Drugs
sirolimus
03
Conditions
lymphangioma
Beyond the preview
Go deeper on 2018-001359-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-001359-11.